Erratum: Correctors of dF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein (FASEB Journal (2013) 27 (536 -545) DOI:10.1096/fj.12-216119);Correctors of δF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein

FASEB Journal

Volumn 27, Issue 2, 2013, Pages 536-545

  He, Lihua ^a   Kota, Pradeep ^a,b   Aleksandrov, Andrei A ^a   Cui, Liying ^a   Jensen, Tim ^a   Dokholyan, Nikolay V ^a   Riordan, John R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

ABC transporter; Anion channel; Cystic fibrosis; Domain interactions; Molecular docking; VX 809

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; LUMACAFTOR; MUTANT PROTEIN;

ALLOSTERISM; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; QUALITY CONTROL; THERMOSTABILITY;

EID: 84873436500     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-216119ERR     Document Type: Erratum

References (44)

1. Bartlett, J. R., Friedman, K. J., Ling, S. C., Pace, R. G., Bell, S. C., Bourke, B., Castaldo, G., Castellani, C., Cipolli, M., Colombo, C., Colombo, J. L., Debray, D., Fernandez, A., Lacaille, F., Macek, M., Jr., Rowland, M., Salvatore, F., Taylor, C. J., Wainwright, C., Wilschanski, M., Zemkova, D., Hannah, W. B., Phillips, M. J., Corey, M., Zielenski, J., Dorfman, R., Wang, Y., Zou, F., Silverman, L. M., Drumm, M. L., Wright, F. A., Lange, E. M., Durie, P. R., and Knowles, M. R. (2009) Genetic modifiers of liver disease in cystic fibrosis. JAMA 302, 1076-1083
2. Cutting, G. R. (2010) Modifier genes in mendelian disorders: The example of cystic fibrosis. Ann. N. Y. Acad. Sci. 1214, 57-69
3. Dorfman, R., Li, W., Sun, L., Lin, F., Wang, Y., Sandford, A., Pare, P. D., McKay, K., Kayserova, H., Piskackova, T., Macek, M., Czerska, K., Sands, D., Tiddens, H., Margarit, S., Repetto, G., Sontag, M. K., Accurso, F. J., Blackman, S., Cutting, G. R., Tsui, L. C., Corey, M., Durie, P., Zielenski, J., and Strug, L. J. (2009) Modifier gene study of meconium ileus in cystic fibrosis: Statistical considerations and gene mapping results. Hum. Genet. 126, 763-778
4. Mickle, J. E., and Cutting, G. R. (2000) Genotype-phenotype relationships in cystic fibrosis. Med. Clin. North Am. 84, 597-607
5. Van Goor, F., Hadida, S., Grootenhuis, P. D., Burton, B., Cao, D., Neuberger, T., Turnbull, A., Singh, A., Joubran, J., Hazlewood, A., Zhou, J., McCartney, J., Arumugam, V., Decker, C., Yang, J., Young, C., Olson, E. R., Wine, J. J., Frizzell, R. A., Ashlock, M., and Negulescu, P. (2009) Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc. Natl. Acad. Sci. U. S. A. 106, 18825-18830
6. Yu, H., Burton, B., Huang, C. J., Worley, J., Cao, D., Johnson, J. P., Jr., Urrutia, A., Joubran, J., Seepersaud, S., Sussky, K., Hoffman, B. J., and Van Goor, F. (2012) Ivacaftor potentiation of multiple CFTR channels with gating mutations. J. Cyst. Fibros. 11, 237-245
7. Van Goor, F., Hadida, S., Grootenhuis, P. D., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., Wine, J. J., Frizzell, R. A., Ashlock, M., and Negulescu, P. A. (2011) Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc. Natl. Acad. Sci. U. S. A. 108, 18843-18848
8. Lukacs, G. L., and Verkman, A. S. (2012) CFTR: Folding, misfolding and correcting the DeltaF508 conformational defect. Trends Mol. Med. 18, 81-91
9. Rabeh, W. M., Bossard, F., Xu, H., Okiyoneda, T., Bagdany, M., Mulvihill, C. M., Du, K., di Bernardo, S., Liu, Y., Konermann, L., Roldan, A., and Lukacs, G. L. (2012) Correction of both NBD1 energetics and domain interface is required to restore DeltaF508 CFTR folding and function. Cell 148, 150-163
10. Mendoza, J. L., Schmidt, A., Li, Q., Nuvaga, E., Barrett, T., Bridges, R. J., Feranchak, A. P., Brautigam, C. A., and Thomas, P. J. (2012) Requirements for efficient correction of DeltaF508 CFTR revealed by analyses of evolved sequences. Cell 148, 164-174
11. Serohijos, A. W., Hegedus, T., Aleksandrov, A. A., He, L., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008) Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc. Natl. Acad. Sci. U. S. A. 105, 3256-3261
12. Cui, L., Aleksandrov, L., Chang, X. B., Hou, Y. X., He, L., Hegedus, T., Gentzsch, M., Aleksandrov, A., Balch, W. E., and Riordan, J. R. (2007) Domain interdependence in the biosynthetic assembly of CFTR. J. Mol. Biol. 365, 981-994
13. He, L., Aleksandrov, A. A., Serohijos, A. W., Hegedus, T., Aleksandrov, L. A., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008) Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating. J. Biol. Chem. 283, 26383-26390
14. Aleksandrov, A. A., Kota, P., Aleksandrov, L. A., He, L., Jensen, T., Cui, L., Gentzsch, M., Dokholyan, N. V., and Riordan, J. R. (2010) Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR. J. Mol. Biol. 401, 194-210
15. Ding, F., Yin, S., and Dokholyan, N. V. (2010) Rapid flexible docking using a stochastic rotamer library of ligands. J. Chem. Inf. Model. 50, 1623-1632
16. Yin, S., Biedermannova, L., Vondrasek, J., and Dokholyan, N. V. (2008) MedusaScore: An accurate force field-based scoring function for virtual drug screening. J. Chem. Inf. Model. 48, 1656-1662
17. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., and Welsh, M. J. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperaturesensitive. Nature 358, 761-764
18. Thibodeau, P. H., Richardson, J. M., 3rd, Wang, W., Millen, L., Watson, J., Mendoza, J. L., Du, K., Fischman, S., Senderowitz, H., Lukacs, G. L., Kirk, K., and Thomas, P. J. (2010) The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J. Biol. Chem. 285, 35825-35835
19. Wang, X., Koulov, A. V., Kellner, W. A., Riordan, J. R., and Balch, W. E. (2008) Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking. Traffic 9, 1878-1893
20. Kopito, R. R. (1999) Biosynthesis and degradation of CFTR. Physiol. Rev. 79, S167-S173
21. Sharma, M., Benharouga, M., Hu, W., and Lukacs, G. L. (2001) Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments. J. Biol. Chem. 276, 8942-8950
22. DeCarvalho, A. C., Gansheroff, L. J., and Teem, J. L. (2002) Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator delta f508. J. Biol. Chem. 277, 35896-35905
23. Hoelen, H., Kleizen, B., Schmidt, A., Richardson, J., Charitou, P., Thomas, P. J., and Braakman, I. (2010) The primary folding defect and rescue of Delta F508 CFTR emerge during translation of the mutant domain. PLoS One 5, e15458
24. Aleksandrov, A. A., Kota, P., Cui, L., Jensen, T., Alekseev, A. E., Reyes, S., He, L., Gentzsch, M., Aleksandrov, L. A., Dokholyan, N. V., and Riordan, J. R. (2012) Allosteric modulation balances thermodynamic stability and restores function of Delta F508 CFTR. J. Mol. Biol. 419, 41-60
25. Schultz, B. D., Frizzell, R. A., and Bridges, R. J. (1999) Rescue of dysfunctional deltaF508-CFTR chloride channel activity by IBMX. J. Membr. Biol. 170, 51-66
26. Liu, X., O'Donnell, N., Landstrom, A., Skach, W. R., and Dawson, D. C. (2012) Thermal instability of Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: Protection by single suppressor mutations and inhibiting channel activity. Biochemistry 51, 5113-5124
27. Liu, X., O'Donnell, N., Landstrom, A., Skach, W. R., and Dawson, D. C. (2012) Thermal instability of Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) cannel function: Protection by single suppressor mutations and inhibiting channel activity. Biochemistry In press
28. Wang, W., Okeyo, G. O., Tao, B., Hong, J. S., and Kirk, K. L. (2011) Thermally unstable gating of the most common cystic fibrosis mutant channel (Delta F508): "rescue" by suppressor mutations in nucleotide binding domain 1 and by constitutive mutations in the cytosolic loops. J. Biol. Chem. 286, 41937-41948
29. Zhang, F., Kartner, N., and Lukacs, G. L. (1998) Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat. Struct. Biol. 5, 180-183
30. Du, K., Sharma, M., and Lukacs, G. L. (2005) The Delta F508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat. Struct. Mol. Biol. 12, 17-25
31. Loo, T. W., Bartlett, M. C., and Clarke, D. M. (2010) The V510D suppressor mutation stabilizes Delta F508-CFTR at the cell surface. Biochemistry 49, 6352-6357
32. Protasevich, I., Yang, Z., Wang, C., Atwell, S., Zhao, X., Emtage, S., Wetmore, D., Hunt, J. F., and Brouillette, C. G. (2010) Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotidebinding domain 1. Protein Sci. 19, 1917-1931
33. Seibert, F. S., Linsdell, P., Loo, T. W., Hanrahan, J. W., Clarke, D. M., and Riordan, J. R. (1996) Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J. Biol. Chem. 271, 15139-15145
34. Seibert, F. S., Linsdell, P., Loo, T. W., Hanrahan, J. W., Riordan, J. R., and Clarke, D. M. (1996) Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity. J. Biol. Chem. 271, 27493-27499
35. Seibert, F. S., Jia, Y., Mathews, C. J., Hanrahan, J. W., Riordan, J. R., Loo, T. W., and Clarke, D. M. (1997) Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel. Biochemistry 36, 11966-11974
36. Mittre, H., Leymarie, P., and Leporrier, N. (1995) High incidence of delta I507 mutation of the CFTR gene in a limited area of the north west of France. J. Med. Genet. 32, 577
37. Scotet, V., Barton, D. E., Watson, J. B., Audrezet, M. P., McDevitt, T., McQuaid, S., Shortt, C., De Braekeleer, M., Ferec, C., and Le Marechal, C. (2003) Comparison of the CFTR mutation spectrum in three cohorts of patients of Celtic origin from Brittany (France) and Ireland. Hum. Mutat. 22, 105
38. Knapp, J. M., Wood, A. B., Phuan, P. W., Lodewyk, M. W., Tantillo, D. J., Verkman, A. S., and Kurth, M. J. (2012) Structure-activity relationships of cyanoquinolines with correctorpotentiator activity in DeltaF508 cystic fibrosis transmembrane conductance regulator protein. J. Med. Chem. 55, 1242-1251
39. Phuan, P. W., Yang, B., Knapp, J. M., Wood, A. B., Lukacs, G. L., Kurth, M. J., and Verkman, A. S. (2011) Cyanoquinolines with independent corrector and potentiator activities restore DeltaPhe508-cystic fibrosis transmembrane conductance regulator chloride channel function in cystic fibrosis. Mol. Pharmacol. 80, 683-693
40. He, L., Aleksandrov, L. A., Cui, L., Jensen, T. J., Nesbitt, K. L., and Riordan, J. R. (2010) Restoration of domain folding and interdomain assembly by second-site suppressors of the DeltaF508 mutation in CFTR. FASEB J. 24, 3103-3112
41. Mornon, J. P., Lehn, P., and Callebaut, I. (2009) Molecular models of the open and closed states of the whole human CFTR protein. Cell. Mol. Life Sci. 66, 3469-3486
42. Alexander, C., Ivetac, A., Liu, X., Norimatsu, Y., Serrano, J. R., Landstrom, A., Sansom, M., and Dawson, D. C. (2009) Cystic fibrosis transmembrane conductance regulator: Using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore. Biochemistry 48, 10078-10088
43. Dalton, J., Kalid, O., Schushan, M., Ben-Tal, N., and Villa-Freixa, J. (2012) New model of cystic fibrosis transmembrane conductance regulator proposes active channel-like conformation. J. Chem. Inf. Model. 52, 1842-1853
44. Kalid, O., Mense, M., Fischman, S., Shitrit, A., Bihler, H., Ben-Zeev, E., Schutz, N., Pedemonte, N., Thomas, P. J., Bridges, R. J., Wetmore, D. R., Marantz, Y., and Senderowitz, H. (2010) Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening. J. Comput. Aided Mol. Des. 24, 971-991